Delivery Order SPE2DB22D2007-SPE2DB24FJ0FU
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,932.75 firm-fixed-price delivery order is for the supply of Lidocaine 5% Patch 30s, a medical product used for pain relief. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% patches. The $3,543.95 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,173.58 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a division of parent company Cencora, Inc., is for the delivery of Lidocaine 5% Patches in the amount of $2,673.17. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of May 19, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA). The contract, valued at $4,561.79, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle...
- This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor, Amerisourcebergen Drug Corp, was awarded a Firm Fixed Price Delivery Order valued at $2,093.83 with a completion date of February 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $1,113.39 for the supply of Lidocaine 5% Patches. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp as the prime contractor. This delivery order is part of a larger, single-award Indefinite Delivery Contract (IDC) issued by DLA to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,729.60 firm fixed-price delivery order is for Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,080.96 for the supply of Lidocaine 5% Patches. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of April 6, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,182.91 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lidocaine 5% Patches to support military healthcare programs. The award has an ultimate completion date of October 19, 2023, and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0FUDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lidocaine 5% Patches over a 2-year period ending in March 2024. The $2,531.78 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, as well as a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, to provide a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/6/24 |